Ekso Bionics (EKSO) Misses Q4 EPS by 2c

Ekso Bionics (NASDAQ: EKSO) reported Q4 EPS of ($0.24), $0.02 worse than the analyst estimate of ($0.22). Revenue for the quarter came in at $3.6 million versus the consensus estimate of $3.94 million.

For earnings history and earnings-related data on Ekso Bionics (EKSO) click here.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• RBC Capital Downgrades Bucher Industries AG (BUCN:SW) (BCHHF) to Sector Perform
• RBC Capital Upgrades GEA Group AG (G1A:GR) (GEAGY) to Outperform